45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,139
Insurances with rates
19
CPT / HCPCS codes
2,960
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9272 | INJECTION; DOSTARLIMAB-GXLY; 10 MG | $88,178 | $52,907 | — | — | 0 |
| 00173-0898-03 | Jemperli | $86,739 | $52,043 | — | — | 0 |
| J9271 | INJECTION; PEMBROLIZUMAB; 1 MG | $84,118 | $50,471 | — | — | 0 |
| 00006-3026-01 | Keytruda | $84,118 | $50,471 | — | — | 0 |
| 00310-4611-50 | Imfinzi | $64,470 | $38,682 | — | — | 0 |
| 51144-0030-01 | Padcev | $58,549 | $35,129 | — | — | 0 |
| 50242-0917-01 | Tecentriq | $56,309 | $33,786 | — | — | 0 |
| J9177 | INJECTION; ENFORTUMAB VEDOTIN-EJFV; 0.25 MG | $53,733 | $32,240 | — | — | 0 |
| J9144 | INJECTION; DARATUMUMAB; 10 MG AND HYALURONIDASE-FIHJ | $52,910 | $31,746 | — | — | 0 |
| 57894-0503-01 | Darzalex Faspro | $52,910 | $31,746 | — | — | 0 |
| J9055 | INJECTION; CETUXIMAB; 10 MG | $49,491 | $29,694 | — | — | 0 |
| 66733-0958-23 | Erbitux | $47,043 | $28,226 | — | — | 0 |
| 00006-3026-04 | Keytruda | $42,084 | $25,251 | — | — | 0 |
| 00003-3734-13 | Opdivo | $37,475 | $22,485 | — | — | 0 |
| J9352 | INJECTION; TRABECTEDIN; 0.1 MG | $36,944 | $22,166 | — | — | 0 |
| 59676-0610-01 | Yondelis | $36,944 | $22,166 | — | — | 0 |
| 50242-0044-06 | INJECTION; ALTEPLASE RECOMBINANT; 1 MG | $31,101 | $18,660 | — | — | 0 |
| J2506 | INJECTION; PEGFILGRASTIM; EXCLUDES BIOSIMILAR; 0.5 MG | $30,090 | $18,054 | — | — | 0 |
| 55513-0192-01 | Neulasta Onpro | $30,090 | $18,054 | — | — | 0 |
| 33208 | INSRT HEART PM ATRIAL & VENT | $29,677 | $17,806 | — | — | 1 |
| C1722 | CARDIOVERTER-DEFIBRILLATOR; SINGLE CHAMBER (IMPLANTABLE) | $28,750 | $17,250 | — | — | 1 |
| J0741 | INJECTION; CABOTEGRAVIR AND RILPIVIRINE; 2MG/3MG | $25,271 | $15,162 | — | — | 0 |
| 33206 | INSERT HEART PM ATRIAL | $24,044 | $14,427 | — | — | 1 |
| 50242-0077-01 | Herceptin Hylecta | $23,426 | $14,056 | — | — | 0 |
| 70594-0111-01 | Acetylcysteine | $23,249 | $13,949 | — | — | 0 |
| 36563 | INSERT TUNNELED CV CATH | $22,705 | $13,623 | — | — | 2 |
| 36583 | REPLACE TUNNELED CV CATH | $22,705 | $13,623 | — | — | 2 |
| 33214 | UPGRADE OF PACEMAKER SYSTEM | $22,165 | $13,299 | — | — | 1 |
| 69448-0027-63 | Udenyca Onbody | $20,887 | $12,532 | — | — | 0 |
| 49702-0264-23 | Apretude | $20,138 | $12,083 | — | — | 0 |
| 33212 | INSERT PULSE GEN SNGL LEAD | $19,112 | $11,467 | — | — | 2 |
| 33213 | INSERT PULSE GEN DUAL LEADS | $17,504 | $10,502 | — | — | 1 |
| 57970-0100-01 | Dalvance | $16,680 | $10,008 | — | — | 0 |
| 55513-0730-01 | Xgeva | $15,408 | $9,245 | — | — | 0 |
| J0897 | INJECTION; DENOSUMAB; 1 MG | $15,408 | $9,245 | — | — | 0 |
| 36566 | INSERT TUNNELED CV CATH | $15,024 | $9,015 | — | — | 2 |
| C1764 | EVENT RECORDER; CARDIAC (IMPLANTABLE) | $13,250 | $7,950 | — | — | 1 |
| J9217 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION); 7.5 MG | $13,051 | $7,830 | — | — | 0 |
| 62935-0461-50 | Eligard | $13,051 | $7,830 | — | — | 0 |
| 33217 | INSERT 2 ELECTRODE PM-DEFIB | $11,444 | $6,866 | — | — | 1 |
| 33210 | INSERT ELECTRD/PM CATH SNGL | $11,444 | $6,866 | — | — | 1 |
| 33216 | INSERT 1 ELECTRODE PM-DEFIB | $11,444 | $6,866 | — | — | 1 |
| J9202 | GOSERELIN ACETATE IMPLANT; PER 3.6 MG | $10,312 | $6,187 | — | — | 0 |
| 70720-0951-30 | Zoladex | $10,312 | $6,187 | — | — | 0 |
| 13533-0318-01 | HyperRAB | $10,208 | $6,125 | — | — | 0 |
| Q5117 | INJECTION; TRASTUZUMAB-ANNS; BIOSIMILAR; (KANJINTI); 10 MG | $10,029 | $6,018 | — | — | 1 |
| 51144-0020-01 | Padcev | $9,795 | $5,877 | — | — | 0 |
| 55513-0141-01 | Kanjinti | $9,770 | $5,862 | — | — | 0 |
| J3315 | INJECTION; TRIPTORELIN PAMOATE; 3.75 MG | $9,402 | $5,641 | — | — | 0 |
| 49281-0190-20 | Imogam Rabies-HT | $9,273 | $5,564 | — | — | 0 |
Showing top 50 of 4,139 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.